| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |